by Matthew Johnson | Jun 3, 2022 | Claim Construction, District Court, PTAB News
By Anthony Bautista and Matt Johnson – In XR Communications, LLC v. D-Link Systems, Inc. Et. Al., a judge in the Central District of California found that certain asserted claims claiming to wireless communication technology were barred by the doctrine of...
by Matthew Johnson | Jun 2, 2022 | PTAB News, Trial Institution
By Hannah Mehrle and Matt Johnson – F5 Networks, Inc. (“Petitioner”) filed a Petition requesting an IPR. WSOU Investments, LLC d/b/a/ Brazos Licensing and Development (“Patent Owner”) filed a Preliminary Response. Here, the PTAB exercised its discretion under...
by Matthew Johnson | May 27, 2022 | Final Written Decisions, PTAB News
By Jareli Reynoso Gutierrez and Matt Johnson – On March 3, 2022, Andrew Hirshfeld, the Commissioner for Patents and acting Director of the USPTO, issued the third post-Arthrex grant of Director Review for two separate Final Written Decisions issued by the PTAB...
by Matthew Johnson | May 13, 2022 | PTAB News, PTAB Trial Basics
By Haytham Soliman and Matt Johnson – The PTAB recently denied institution of inter partes review (IPR) for claims 1 and 46 of U.S. 7,464,040 in eClinicalWorks, LLC et al. v. Decapolis Systems, LLC, IPR2022-0229, Paper 10 (PTAB April 13, 2022). The denial was...
by Matthew Johnson | May 2, 2022 | 325(d) issues, Prior Art Issues, PTAB News
By Haytham Soliman and Matt Johnson – The Board denied post grant review in Palo Alto Networks, Inc. v. Centripetal Networks, Inc. under 35 U.S.C. § 325(d) after applying the Advanced Bionics[1] framework as informed by the factors outlined in Becton.[2] ...
by Sarah Geers | Apr 27, 2022 | PTAB News, Trial Institution
By Sarah Geers – The PTAB recently issued a rare decision instituting a derivation proceeding, in Global Health Solutions LLC v. Selner, DER2017-00031 (“GHC”). The GHC institution decision provides several lessons for future petitioners looking to avoid...